A detailed history of Cetera Investment Advisers transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 19,012 shares of ALDX stock, worth $91,067. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,012
Previous 17,977 5.76%
Holding current value
$91,067
Previous $59,000 72.88%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.19 - $6.32 $3,301 - $6,541
1,035 Added 5.76%
19,012 $102,000
Q1 2024

May 24, 2024

BUY
$2.77 - $4.22 $49,796 - $75,862
17,977 New
17,977 $58,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Cetera Investment Advisers Portfolio

Follow Cetera Investment Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.